Okines A, et al. – This article was written with the objective to evaluate the frequency of brain progression in clinical practice, without routine baseline imaging. In patients not screened for brain metastases at baseline, the brain was the first site of progression in a significant proportion. Baseline brain imaging may have a role in standard practice for patients commencing trastuzumab emtansine (T–DM1) therapy.